MAPK3 and chronic kidney disease: Several signaling pathways have been implicated in fibrosis development after ischemia, and various studies clearly indicate that both ERK1/2 and mTOR have multiple crosstalks with the pathophysiological mechanisms operating in CKD [11,12].